Accelerated atherosclerotic calcification and mönckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 6, 2008, Pages 1585-1598

  McCullough, Peter A ^a   Agrawal, Varun ^a   Danielewicz, Ewa ^b   Abela, George S ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; BLOOD; CALCINOSIS; CHILD; CHRONIC DISEASE; DISEASE COURSE; HUMAN; INTIMA; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; PATHOLOGY; PRESCHOOL CHILD; REVIEW; RISK FACTOR; TUNICA MEDIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CALCINOSIS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; MIDDLE AGED; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; YOUNG ADULT;

EID: 58149352649     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01930408     Document Type: Article

References (68)

1. Whaley-Connell AT, Sowers JR, McFarlane SI, Norris KC, Chen SC, Li S, Qiu Y, Wang C, Stevens LA, Vassalotti JA, Collins AJ, Kidney Early Evaluation Program Investigators: Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51[Suppl 2]: S21-S29, 2008
2. McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT, Kidney Early Evaluation Program Investigators: CKD and cardiovascular disease in screened high-risk volunteer and general populations: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51[Suppl 2]: S38-S45, 2008
3. Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell AT, McCullough PA, Norris KC, Kidney Early Evaluation Program Investigators: Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51[Suppl 2]: S56-S68, 2008
4. Mönckeberg JG: Ueber die reine Mediaverkalkung der Extremitaetenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch Pathol Anat 171: 141-167, 1903
5. Faber A: Die Arteriosklerose, ihre pathologische Anatomie, ihre Pathogenese und Aetiologie, Jena, G. Fisher, 1912
6. Eggen DA, Strong JP, McGill HC Jr: Coronary calcification: Relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation 32: 948-955, 1965
7. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374, 1995
8. Amillo Garayoa S, Leyes Vence M, Arriola Guenaga FJ: Transfer of the second toe to the hand in a patient with Monckeberg's sclerosis. Scand J Plast Reconstr Surg Hand Surg 31: 181-183, 1997
9. Top C, Cankir Z, Silit E, Yildirim S, Danaci M: Mönckeberg's sclerosis: An unusual presentation - A case report. Angiology 53: 483-486, 2002
10. Shabat S, Mann G, Stern A, Nyska M, Witz M: Popliteal artery rupture during total knee replacement in a patient with Mönckeberg's sclerosis: Case report. J Knee Surg 17: 117-119, 2004
11. Couri CE, da Silva GA, Martinez JA, Pereira Fde A, de Paula FJ. Mönckeberg's sclerosis: Is the artery the only target of calcification? BMC Cardiovasc Disord 5: 34, 2005
12. Sorensen MD, Long LO, Wessells H, Kuan JK: Monckeberg's calciphylaxis with necrosis of the glans penis: A case presentation. Hemodial Int 11: 300-302, 2007
13. Goebel FD, Füessl HS: Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 24: 347-350, 1983
14. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176, 1999
15. Castillo BV Jr, Torczynski E, Edward DP: Monckeberg's sclerosis in temporal artery biopsy specimens. Br J Ophthalmol 83: 1091-1092, 1999
16. Schoppet M, Al-Fakhri N, Franke FE, Katz N, Barth PJ, Maisch B, Preissner KT, Hofbauer LC: Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab 89: 4104-4112, 2004
17. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC: Mönckeberg sclerosis revisited: A clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med 132: 43-47, 2008
18. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM,, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809, 1993
19. Tammura A, McGregor DH, Anderson HC: Calcification in atherosclerosis, I: Human studies. J Exp Pathol 2: 261-273, 1986
20. Tanimura A, McGregor DH, Anderson HC: Calcification in atherosclerosis, II: Animal studies. J Exp Pathol 2: 275-297, 1986
21. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007 116: 85-97, 2007
22. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007
23. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G, Cholesterol and Recurrent Events Trial Investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005
24. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005
25. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Fluisman RM, Krediet RT, Dekker FW, PREPARE study group: High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22: 2909-2916, 2007
26. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
27. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA: Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: A quantitative pathologic comparison study. J Am Coll Cardiol 20: 1118-1126, 1992
28. McCullough PA, Soman S: Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor? Kidney Int Suppl 90: S18-S24, 2004
29. Summers RM, Andrasko-Bourgeois J, Feuerstein IM, Hill SC, Jones EC, Busse MK, Wise B, Bove KE, Rishforth BA, Tucker E, Spray TL, Hoeg JM: Evaluation of the aortic root by MRI: Insights from patients with homozygous familial hypercholesterolemia. Circulation 98: 509 -518, 1998
30. Kallen RJ, Brynes RK, Aronson AJ, Lichtig C, Spargo BH: Premature coronary atherosclerosis in a 5-year-old with corticosteroid-refractory nephrotic syndrome. Am J Dis Child 131: 976-980, 1977
31. Curry RC Jr, Roberts WC: Status of the coronary arteries in the nephrotic syndrome: Analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated. Am J Med 63: 183-192, 1977
32. Yerkey MW, Kernis SJ, Franklin BA, Sandberg KR, McCullough PA: Renal dysfunction and acceleration of coronary disease. Heart 90: 961-966, 2004
33. Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG, Health ABC study: Kidney dysfunction and fatal cardiovascular disease: An association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. Am Heart J 155: 62-68, 2008
34. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61: 638-647, 2002
35. Wilkinson FL, Liu Y, Rucka AK, Jeziorska M, Hoyland JA, Heagerty AM, Canfield AE, Alexander MY: Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 211: 362-369, 2007
36. Rokita E, Cichocki T, Heck D, Jarczyk L, Strzatkowski A: Calcification of aortic wall in cholesterol-fed rabbits. Atherosclrosis 87: 183-193, 1991
37. Hsu HH, Camacho NC, Tawfik O, Sun F: Induction of calcification in rabbit aortas by high cholesterol diets: Roles of calcifiable vesicles in dystrophic calcification. Atherosclerosis 161: 85-94, 2002
38. Peters F, Epple M: Simulating arterial wall calcification in vitro: Biomimetic crystallization of calcium phosphates under controlled conditions. Z Kardiol 90: III81-III85, 2000
39. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG: Influence of lipia-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. Circulation 106: 1077-1082, 2002
40. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972-1978, 1998
41. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD: Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 46: 166-172, 2005
42. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA: Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112: 563-571, 2005
43. Schmermund A, Achenbach S, Budde T, Buziashvili Y, Förster A, Friedrich G, Henein M, Kerkhoff G, Knollmann F, Kukharchuk V, Lahiri A, Leischik R, Moshage W, Schartl M, Siffert W, Steinhagen-Thiessen E, Sinitsyn V, Vogt A, Wiedeking B, Erbel R: Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, double-blind trial. Circulation 113: 427-437, 2006
44. Houslay ES, Cowell SJ, Prescott RJ, Reid J, Burton J, Northridge DB, Boon NA, Newby DE, Scottish Aortic Stenosis and Lipid Lowering Therapy, Impact on Regression trial Investigators: Progressive coronary calcification despite intensive lipid-lowering treatment: A randomised controlled trial. Heart 92: 1207-1212, 2006
45. Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, Chandler ET, Morgan T, Crouse JR 3rd: Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the Coronary Artery Calcification Treatment with Zocor [CATZ] study). Am J Cardiol 99: 1714-1717, 2007
46. McCullough PA, Sandberg KR, Dumler F, Yanez JE: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: A systematic review. J Nephrol 17: 205-215, 2004
47. Chertow GM, Burke SK, Raggi P, for the Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002
48. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M, on behalf of the CARE-2 Investigators: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. Am J Kidney Dis 51: 952-965, 2008
49. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68: 1815-1824, 2005
50. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable hpid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 51: 952-965, 2008
51. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72: 1130-1137, 2007
52. Nayir A, Bilge I, Kiliçaslan I, Ander H, Emre S, Sirin A: Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16: 2041-2047, 2001
53. Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, Nagai R, Horiuchi S: Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 18: 1601-1609, 2003
54. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, Berger I, Adamczak M, Schirmacher P, Ritz E: Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2: 121-134, 2007
55. Chowdhury UK, Airan B, Mishra PK, Kothari SS, Subramaniam GK, Ray R, Singh R, Venugopal P: Histopathology and morphometry of radial artery conduits: Basic study and clinical application. Ann Thorac Surg 78: 1614-1621, 2004
56. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15: 218-223, 2000
57. Clyne N, Lins LE, Pehrsson SK: Occurrence and significance of heart disease in uraemia: An autopsy study. Scand J Urol Nephrol 20: 307-311, 1986
58. Lindner A, Charra B, Sherrarg DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
59. Lewin K, Trautman L: Ischaemic myocardial damage in chronic renal failure. BMJ 4: 151-152, 1971
60. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC: Medial calcinosis of Mönckeberg: A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med 63: 615-622, 1977
61. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R 3rd: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66: 790-796, 1979
62. Qiao JH, Doherty TM, Fishbein MC, Salusky IB, Luthringer DL, Fitzpatrick LA, Shah PK, Rajavashisth TB: Calcification of the coronary arteries in the absence of atherosclerotic plaque. Mayo Clin Proc 80: 807-809, 2005
63. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16: 600-611, 1979
64. Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 16: 31-36, 1993
65. Curry RC Jr, Roberts WC: Status of the coronary arteries in the nephrotic syndrome: Analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated. Am J Med 63: 183-192, 1997
66. Ibels LS, Stewart JH, Mahony JF, Sheil AG: Deaths from occlusive arterial disease in renal allograft recipients. BMJ 3: 552-554, 1974
67. Ori Y, Chagnac A, Schwartz A, Herman M, Weinstein T, Zevin D, Gafter U, Korzets A: Non-occlusive mesenteric ischemia in chronically dialyzed patients: A disease with multiple risk factors. Nephron Clin Pract 101: c87-c93, 2005
68. Antikainen M, Sariola H, Rapola J, Taskinen MR, Holthöfer H, Holmberg C: Pathology of renal arteries of dyslipidemic children with congenital nephrosis. APMIS 102: 129-134, 1994